ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 171 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $468,440 | +174041.3% | 478,000 | +282740.2% | 0.02% | – |
| Q1 2023 | $269 | – | 169 | +218.9% | 0.00% | – |
| Q3 2022 | $0 | – | 53 | +51.4% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 35 | -97.7% | 0.00% | – |
| Q4 2021 | $8,000 | +300.0% | 1,526 | +1111.1% | 0.00% | – |
| Q3 2021 | $2,000 | – | 126 | +6200.0% | 0.00% | – |
| Q2 2021 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 2 | -60.0% | 0.00% | – |
| Q4 2020 | $0 | – | 5 | -50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 10 | -99.9% | 0.00% | -100.0% |
| Q1 2020 | $558,000 | -47.2% | 17,710 | 0.0% | 0.04% | -43.0% |
| Q4 2019 | $1,056,000 | +273.1% | 17,710 | +129.7% | 0.08% | +229.2% |
| Q3 2019 | $283,000 | +253.8% | 7,710 | +285.5% | 0.02% | +166.7% |
| Q1 2019 | $80,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,679,835 | $69,675,000 | 19.39% |
| Endurant Capital Management LP | 207,293 | $5,390,000 | 1.94% |
| Bellevue Group AG | 5,138,451 | $133,599,000 | 1.53% |
| Rhenman & Partners Asset Management AB | 592,225 | $15,398,000 | 1.26% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,562,869 | $40,635,000 | 0.93% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 31,434 | $817,000 | 0.62% |
| WASATCH ADVISORS LP | 3,998,010 | $103,949,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 46,181 | $1,201,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $13,000,000 | 0.42% |
| DCF Advisers, LLC | 38,500 | $1,001,000 | 0.41% |